ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 821

Discrepancies between Clinical- and Imaging-Based Assessments of Disease Activity in Takayasu’s Arteritis

Peter C. Grayson1, Mark Ahlman2, Kathleen Marinelli3, Renee Borchin4, Simon Carette5, Nader A. Khalidi6, Carol A. Langford7, Carol A. McAlear8, Paul A. Monach9, Christian Pagnoux5, Kenneth J. Warrington10, Steven R. Ytterberg10 and Peter A. Merkel11, 1National Institute of Arthritis, Musculoskeletal and Skin Disease (NIAMS), Bethesda, MD, 2Radiology and Imaging Sciences, National Institutes of Health, Bethesda, MD, 3NIAMS, National Institutes of Health, Bethesda, MD, 4University of South Florida, Tampa, FL, 5Division of Rheumatology, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada, 6Rheumatology, McMaster University, Hamilton, ON, Canada, 7Rheumatic and Immunologic Diseases, Cleveland Clinic, Cleveland, OH, 8University of Pennsylvania, Philadelphia, PA, 9Boston University School of Medicine, Boston, MA, 10Rheumatology, Mayo Clinic, Rochester, MN, 11Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, PA

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Imaging, positron emission tomography (PET), takayasu arteritis and vasculitis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 5, 2017

Session Title: Vasculitis Poster I: Large Vessel Vasculitis

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: To study the relationship between clinically-determined disease activity and vascular inflammation assessed by positron emission tomography (PET) in patients with TakayasuÕs arteritis (TAK).

Methods: Patients with new or relapsing TAK were evaluated at 5 centers.  Whole body 18F-flurodeoxyglucose (FDG)PET-CT imaging was performed during a period of clinical disease activity.  Clinical assessments were performed blinded to PET scan findings.  A single nuclear medicine physician interpreted all of the PET scans, blinded to clinical data, to determine presence of active vasculitis based on degree of arterial FDG uptake.  Classification and regression tree analysis (CART) defined predictors of PET scan activity.  Elevated acute phase reactants (ESR>30mm/hr, CRP>10mg/L), prednisone dose at time of imaging, ongoing use of other immunosuppressive agents for >1 month at time of clinical assessment, interval between clinical and imaging assessments, and clinical features of disease activity (vascular vs nonspecific) were studied within the CART models.  Vascular features included asymptomatic disease progression by angiography.  Non-specific features of disease activity were defined as constitutional symptoms accompanied by elevated acute phase reactants in the absence of signs or symptoms of vascular involvement.

Results: Clinical assessments were performed in 25 patients with TAK, and PET scans were performed a mean of 7 days later.  FDG-PET findings were suggestive of active vasculitis in 13 of 25 patients (52%).  Interval increase in glucocorticoid therapy between clinical assessment and imaging occurred in 4/13 (31%) patients with an active scan and 5/12 (42%) patients with an inactive scan (p=0.69).  CART analysis predicted FDG-PET scan activity with 84% accuracy based upon 3 variables: clinical features of disease activity, prednisone dose at the time of imaging, and use of a non-glucocorticoid immunosuppressive agent (Figure).  Acute phase reactants and time interval delay between clinical and imaging assessments were not predictive within the model.  Clinical features of disease were the strongest determinant of vascular activity on FDG-PET.  Among patients with vascular symptoms of disease activity, use of <10mg daily prednisone at the time of imaging assessment and treatment with glucocorticoid monotherapy were associated with increased probability of active vasculitis on FDG-PET.

Conclusion: Clinical features of disease and treatment status are associated with different findings on vascular FDG-PET scan in TAK.  Clinical studies that incorporate imaging-based assessment of disease activity in TAK should ideally obtain baseline imaging studies prior to the initiation of glucocorticoid therapy and should consider exclusion of patients with exclusively non-specific symptoms of disease activity.

Slide1.png


Disclosure: P. C. Grayson, None; M. Ahlman, None; K. Marinelli, None; R. Borchin, None; S. Carette, None; N. A. Khalidi, None; C. A. Langford, None; C. A. McAlear, None; P. A. Monach, None; C. Pagnoux, None; K. J. Warrington, None; S. R. Ytterberg, None; P. A. Merkel, None.

To cite this abstract in AMA style:

Grayson PC, Ahlman M, Marinelli K, Borchin R, Carette S, Khalidi NA, Langford CA, McAlear CA, Monach PA, Pagnoux C, Warrington KJ, Ytterberg SR, Merkel PA. Discrepancies between Clinical- and Imaging-Based Assessments of Disease Activity in Takayasu’s Arteritis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/discrepancies-between-clinical-and-imaging-based-assessments-of-disease-activity-in-takayasus-arteritis/. Accessed January 31, 2023.
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/discrepancies-between-clinical-and-imaging-based-assessments-of-disease-activity-in-takayasus-arteritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences